Key HIV Studies Influencing My Practice Following CROI 2025—Dr Chloe Orkin and Dr Jean-Michel Molina
Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, review key findings from clinical trials on HIV prevention and treatment as well as sexually transmitted infection prevention presented at CROI 2025.
Decera Clinical Education Infectious Disease Podcast · Chloe Orkin MBChB FRCP MD, Jean-Michel Molina MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, discuss highlights from CCO’s independent conference coverage of CROI 2025, including:
- Advances in HIV treatment based on results from CARES
- Potential HIV therapies in the pipeline, such as doravirine/islatravir
- Effects of broadly neutralizing antibodies on HIV treatment and cure
- Key clinical data on HIV and STI prevention obtained from PILLAR, HPTN 083, PURPOSE 1, and STOMP
Presenters:
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Honorary Consultant Physician, Barts Health NHS Trust
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom
Jean-Michel Molina, MD, PhD
Professor of Medicine
University of Paris Cite
Department of Infectious Diseases
Saint-Louis and Lariboisiere Hospitals, APHP
Paris, France
Link to full program:
bit.ly/3E1bAYQ
To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.